Simplex Trading, LLC Verrica Pharmaceuticals Inc. Transaction History

Simplex Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$4.74 - $6.81 $10,589 - $15,213	-2,234 Reduced 49.39%	2,289 $13,000
Q4 2023 Feb 02, 2024	SELL	$2.93 - $7.32 $14,597 - $36,468	-4,982 Reduced 52.41%	4,523 $33,000
Q3 2023 Nov 01, 2023	BUY	$3.75 - $7.46 $31,443 - $62,552	8,385 Added 748.66%	9,505 $36,000
Q2 2023 Aug 04, 2023	BUY	$5.32 - $6.79 $5,958 - $7,604	1,120 New	1,120 $6,000
Q4 2022 Feb 02, 2023	BUY	$2.09 - $3.39 $19,324 - $31,343	9,246 Added 6651.8%	9,385 $25,000
Q3 2022 Nov 04, 2022	SELL	$2.17 - $4.3 $1,742 - $3,452	-803 Reduced 85.24%	139 $0
Q2 2022 Aug 03, 2022	BUY	$1.81 - $8.93 $81 - $401	45 Added 5.02%	942 $1,000
Q2 2021 Aug 12, 2021	BUY	$9.77 - $15.33 $8,763 - $13,751	897 New	897 $10,000

17.4M

6.1K

6.3K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.